Varma Mutual Pension Insurance Co Invests $15.84 Million in Synopsys, Inc. $SNPS

Varma Mutual Pension Insurance Co purchased a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) in the 2nd quarter, HoldingsChannel reports. The firm purchased 35,515 shares of the semiconductor company’s stock, valued at approximately $15,842,000.

A number of other large investors also recently bought and sold shares of SNPS. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Synopsys during the second quarter valued at $747,400,000. Norges Bank acquired a new position in shares of Synopsys during the 4th quarter worth about $730,197,000. SBI Okasan Asset Management Co.Ltd. acquired a new position in shares of Synopsys during the 4th quarter worth about $1,699,000. Atreides Management LP purchased a new position in Synopsys in the 1st quarter valued at about $54,288,000. Finally, Czech National Bank lifted its stake in Synopsys by 4.6% in the 2nd quarter. Czech National Bank now owns 54,526 shares of the semiconductor company’s stock valued at $24,322,000 after buying an additional 2,421 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Wall Street Analysts Forecast Growth

SNPS has been the subject of several research reports. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Needham & Company LLC restated a “buy” rating and issued a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Bank of America raised their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Berenberg Bank set a $633.00 target price on shares of Synopsys in a research note on Wednesday, May 27th. Finally, Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $563.59.

View Our Latest Analysis on SNPS

Synopsys Price Performance

SNPS stock opened at $397.87 on Friday. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $615.79. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The firm has a market capitalization of $76.18 billion, a PE ratio of 92.10, a price-to-earnings-growth ratio of 2.34 and a beta of 1.23. The business has a 50 day simple moving average of $419.73 and a 200-day simple moving average of $440.22.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm’s revenue was up 41.9% compared to the same quarter last year. During the same quarter last year, the business posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.